Administration of G-CSF or GM-CSF theoretically may increase the prevalence of adverse events which include immunologically mediated organ dysfunction, such as acute respiratory distress syndrome (ARDS), to which patients with severe sepsis are particularly prone [49]. Here, CSF2 is linked to acute respiratory distress syndrome.